Abbott Laboratories (ABT)

Accounts Payable

$4.79B

Quarterly · Period ending: · USD

ABT logo

ABT Accounts Payable

Latest reported$4.79B
ABT Quarterly Accounts Payable ($0.00 → $4.79B)
High-resolution chart · PNG

ABT accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Accounts Payable — Quarterly (USD)
Period endingAccounts Payable (USD)
4,794,000,000
4,679,000,000
4,240,000,000
4,123,000,000
4,306,000,000
4,214,000,000
4,195,000,000
4,034,000,000
4,125,000,000
4,178,000,000
4,295,000,000
3,961,000,000
4,211,000,000
4,167,000,000
4,607,000,000
4,133,000,000
4,493,000,000
4,757,000,000
4,408,000,000
4,017,000,000
4,017,000,000
4,066,000,000
3,946,000,000
3,189,000,000
3,335,000,000
3,181,000,000
3,252,000,000
3,029,000,000
3,222,000,000
3,045,000,000
2,975,000,000
2,730,000,000
2,503,000,000
2,476,000,000
2,402,000,000
1,858,000,000
1,667,000,000
1,481,000,000
1,178,000,000
1,051,000,000
1,153,000,000
1,053,000,000
1,081,000,000
1,007,000,000
1,000,000,000
1,012,000,000
1,064,000,000
965,000,000
1,062,000,000
1,074,000,000
1,026,000,000
1,008,912,000
1,042,248,000
1,087,979,000
1,797,000,000
1,605,202,000
1,519,460,000
1,726,962,000
1,721,127,000
1,601,998,000
1,448,555,000
1,577,168,000
1,535,759,000
1,531,720,000
1,615,606,000
1,663,523,000
1,280,542,000
1,394,952,000
1,185,405,000
1,184,761,000
1,351,436,000
1,223,848,000
1,180,397,000
1,228,243,000
1,219,529,000
1,154,396,000
1,061,499,000
987,514,000
1,175,590,000
995,340,000
1,036,931,000
930,821,000
1,032,516,000
1,030,356,000
942,600,000
986,643,000
1,054,464,000
1,597,801,000
1,485,629,000
1,574,940,000
1,078,333,000
1,318,196,000
1,487,956,000
1,618,432,000
1,661,650,000
887,802,000
1,043,758,000
1,017,189,000
1,525,215,000
1,559,357,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.